United States · FDA National Drug Code directory
Bexagliflozin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51407-918_57d77a92-1e20-5a1c-e063-6394a90ae710
- Product NDC
- 51407-918
- Form
- TABLET
- Composition / generic term
- Bexagliflozin
- Labeler
- Golden State Medical Supply, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20230120
- Source listing expiry
- 20271231
Source-listed ingredients
- BEXAGLIFLOZIN — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (51407-918-30) · 51407-918-30
- 90 TABLET in 1 BOTTLE (51407-918-90) · 51407-918-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →